Health Canada has issued a notice of an expanded recall it first issued in June for cannabis products containing an “undeclared intoxicating cannabinoid.”
The updated recall, issued on August 9, adds eight new lots to the voluntary recall, including two new product brands. The issue section in the recall has also been clarified.
In total, 14 lots of iNaturally Organic Inc’s Emprise CBN+CBD 50 mg Softgels, NuLeaf Naturals 1800 mg Full Spectrum Hemp Multicannabinoid Oil Softgels, NuLeaf Naturals 1800 mg Full Spectrum Hemp Multicannabinoid Oil, Ultra Plus 1200 mg MultiCannabinoid Oil and Ultra Plus 750 mg MultiCannabinoid Softgels cannabis extracts have now been recalled.
Inspection, testing, and sampling by Health Canada showed that each sample contained a significant quantity of the intoxicating cannabinoid hexahydrocannabinol (HHC) and of THC in products identified as containing more than three (3) mg per unit (for softgels) or g (for oils).
The presence or quantity of HHC is not indicated on the label. HHC is considered a “semisynthetic CBD,” often synthesized from CBD.
The tests are also said to have shown significantly less cannabichromene (CBC) than identified on the licence holder’s certificate of analysis and/or product labels.
In response to this testing, Alberta’s iNaturally Organic Inc. began a voluntary recall of the affected products that were sold in Ontario, British Columbia, Alberta, Manitoba, Saskatchewan, and the Yukon.
These products were also sold to medical clients through Rosebud Productions Inc. (Herbal Dispatch), Open Fields Winnipeg, Open Fields Saskatchewan, and Médicibis.
Health Canada says that consuming these products when alertness is required could pose “potentially serious adverse health consequences, such as when performing safety-sensitive activities like driving motor vehicles or operating heavy machinery.”
To date, iNaturally Organic Inc. has received two adverse reaction reports about these products, and Health Canada has received five adverse reaction reports and one complaint related to these products.
There were 8,526 units of Emprise CBN+CBD 50 mg Softgels distributed, 2,286 units of NuLeaf Naturals 1800 mg Full Spectrum Hemp Multicannabinoid Oil Softgels distributed, 2,534 units of NuLeaf Naturals 1800 mg Full Spectrum Hemp Multicannabinoid Oil distributed, 3,324 units of Ultra Plus 750 mg MultiCannabinoid Softgels distributed, and 600 units of Ultra Plus 1200 mg MultiCannabinoid Oil distributed.
The recalled products were sold from December 2022 to July 2024.
Health Canada says consumers can return the product to the retailer where it was purchased or dispose of it themselves.
